Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,295.00
Bid: 2,250.00
Ask: 2,340.00
Change: -60.00 (-2.54%)
Spread: 90.00 (4.00%)
Open: 2,370.00
High: 2,300.00
Low: 2,300.00
Prev. Close: 2,360.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of ClaimTrust

18 Feb 2011 07:00

RNS Number : 4559B
Craneware plc
18 February 2011
 



Craneware plc

("Craneware" or the "Company")

 

Acquisition of ClaimTrust

 

18 February 2011 - Craneware (AIM: CRW.L; OTC: CRWRY), the market leader in automated revenue integrity solutions for the US healthcare market, today announces the acquisition of ClaimTrust, Inc., a Software-as-a-Service ("SaaS") revenue cycle technology solutions provider for an initial consideration of $15 million and a maximum total consideration of $19.5 million, subject to certain performance criteria and working capital adjustments. Craneware believes the acquisition, which is its first, will broaden and strengthen its product offering and be earnings enhancing in the first full financial year of ownership.

 

Overview of ClaimTrust:

·; ClaimTrust is a SaaS provider with 100 percent of revenues from healthcare providers in the US & Puerto Rico.

·; Software delivered via multi-tenant platform hosted in ClaimTrust's own, scalable data centre in Nashville.

·; Over 275 customers with an approximate overlap of 10% with Craneware customer base.

·; ClaimTrust reported audited revenues of $8.5 million for financial year ended December 2010 and adjusted EBITDA of $0.9 million. 

·; Approximately 70 percent of ClaimTrust total revenues for the financial year ended December 2010 are contractually recurring from monthly subscriptions.

 

The Acquisition:

·; Provides complementary software and services which will be integrated with the Craneware product suite.

·; Expected to be earnings enhancing in the first full financial year of ownership by Craneware.

·; ClaimTrust's management team and employees integrating into Craneware structure.

·; Opportunity to move new customers of ClaimTrust solutions to Craneware multi-year annuity SaaS revenue model.

·; Initial consideration of $9 million in cash and $6 million in Craneware shares

·; Deferred, contingent consideration up to a maximum of $4.5 million payable in cash and shares if ClaimTrust achieves significant revenue and EBITDA growth in the 12 month period ending 30 June 2012.

 

Information on ClaimTrust

 

Founded in 1998 with offices in Nashville and Boston, ClaimTrust has developed the InSight Revenue Cycle Solution™, a suite of five software solutions and services targeting the revenue cycle. Complementary to Craneware's Revenue Integrity Solutions™, ClaimTrust's offerings improve accuracy of billing and claims in order to ensure that hospitals efficiently collect all of the revenue to which they are entitled. Craneware will continue to invest in and support all ClaimTrust's product lines and create new products based upon the joint technology of the two companies.

 

Delivered via ClaimTrust's data centre in Nashville, the InSight Revenue Cycle Solution software suite is a multi-tenant platform accessed via a web browser and has been developed by ClaimTrust with standard Microsoft development tools, using Microsoft SQL Server. Craneware believes that the technology architecture is robust and scalable for significant organic growth.

 

Acquisition Rationale

 

Increased product offering

 

All of ClaimTrust's products are applicable to the Craneware customer base and target audience. ClaimTrust's five core products will be integrated within the Craneware product suite, complementing existing Craneware product families, enhancing the user experience and broadening the revenue integrity offering.

 

The acquisition will provide a new product family for Craneware - Audit and Revenue Recovery. The first product to be rolled out by Craneware to its customer base from this new product family will be Insight Audit™ a tool used by hospitals to manage their Recovery Audit Contractor (RAC) process and appeals for medical claim audits. ClaimTrust developed this tool following its instrumental support of hospitals involved in the demonstration stage of the Medicare Recovery Audit programme, helping these customers win more than twice as many appeals than their peers nationally and avoiding millions of dollars in unnecessary Medicare RAC denials.

 

With scalability from the rapidly deployed ASP (Application Service Provider) software and limited sales resource currently utilised within ClaimTrust, Craneware believes that by introducing its sales and distribution channels there is an opportunity for growth of sales of the ClaimTrust offerings and the ability to introduce new customers of the ClaimTrust solutions to the more familiar Craneware business model.

 

Increased market share

 

Adding 275 hospital clients to the Craneware group, with an approximate overlap of 10% with Craneware's existing 1000+ hospitals, the acquisition will provide Craneware with further expansion capability for its Revenue Integrity Solutions. With customers that have purchased both companies' solution sets already benefiting from the use of the products in terms of net patient revenue, efficiency and compliance, it is expected that significant incremental benefits will be found by customers that own a greater percentage of the expanded revenue integrity offering.

 

Specialist knowledge

 

The experienced management team and employees of ClaimTrust will be actively involved in the operations of Craneware going forward. Craneware sees this very much as a growth opportunity for both organisations and has structured the terms of the acquisition to encourage active participation in the enlarged company.

 

Consideration

 

The acquisition, via a merger agreement, provides for the purchase of the entire issued and to be issued share capital of ClaimTrust from the vendors for a total consideration (included a deferred compensation component) of up to $19.5 million (subject to working capital adjustments). ClaimTrust, Inc. will be merged into a wholly owned subsidiary of Craneware, Craneware® InSight, Inc. The initial consideration of $9 million in cash and $6 million in shares of the Company (being 641,917 new ordinary shares of 1p each in the capital of the Company ("Ordinary Shares")) will be payable on completion on the basis of net assets of $1.8 million.

 

A deferred, contingent consideration of up to $4.5 million in cash and shares is payable if ClaimTrust achieves significant revenue and EBITDA growth in the 12 month period ending 30 June 2012.

 

The calculations and payment of the deferred, contingent consideration will be made following completion of the audit of ClaimTrust in August 2012.

 

Application for the 641,917 new Ordinary Shares to be admitted to AIM will be made, in weekly aggregate instalments, following satisfaction by each of the vendors of the necessary regulatory documentation. Upon admission, the Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue. Following admission of the 641,917 Ordinary Shares, the total number of Ordinary Shares in the Company with voting rights in issue will be 26,606,867.

 

Joe Ferro, President and CEO of ClaimTrust, commented:"This acquisition allows our two companies to offer the market a broader product range and outstanding customer support. We are looking forward to the increased opportunities this represents for both ClaimTrust and our clients."

 

Keith Neilson, CEO of Craneware, added: "The acquisition of ClaimTrust represents an exciting step forward for Craneware by enhancing our product set, increasing our market share and adding to the profitability of the group.

 

"With the fiscal and regulatory pressures on US hospitals continuing to increase, the addition of ClaimTrust's powerful set of revenue cycle software tools means we can provide our customers with further means of improving the collection of the revenue to which they are entitled.

 

"We are delighted to welcome the ClaimTrust team and their customers into the Craneware group and look forward to continuing to deliver a high level of service to our growing customer base."

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Threadneedle Communications

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Evans-Jones

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta and Arizona, employing over 150 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware's market-driven, annuity SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimise compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com & www.stoptheleakage.com.

 

About ClaimTrust

 

Founded in 1998 with offices in Nashville and Boston, ClaimTrust has developed InSight Revenue Cycle Solution™, a suite of five software solutions and services targeting the revenue cycle. ClaimTrust employs over 50 people, providing services to over 275 hospitals in the US and Puerto Rico. For further information please visit www,claimtrust.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGGUBWPUPGGRM
Date   Source Headline
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSExtension of share buyback programme
15th Apr 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20242:14 pmRNSDividend Currency Election
21st Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSInterim Results
17th Jan 20247:00 amRNSTrading Update and Notice of Results
14th Dec 20234:29 pmRNSNotification of Major Holdings
12th Dec 20232:36 pmRNSNotification of Major Holdings
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSDividend Currency Election
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20236:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Statement
1st Nov 20232:38 pmRNSExercise of SAYE Options, Director Dealing & TVR
25th Oct 20237:00 amRNSDirector Share Purchase
17th Oct 20236:10 pmRNSPosting of Annual Report and Notice of AGM
17th Oct 20239:44 amRNSExtension of share buyback programme
17th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSBlock listing Interim Review
6th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20233:52 pmRNSVesting of Long Term Incentive Plan Awards
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.